TIAA FSB’s Medicines Co MDCO Stock Holding History

TIAA FSB’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60,633	Closed	-$5.15M	–	300
2019 Q4	$5.15M	Hold	60,633	–	–	0.02%	183
2019 Q3	$3.03M	Hold	60,633	–	–	0.02%	200
2019 Q2	$2.21M	Hold	60,633	–	–	0.01%	205
2019 Q1	$1.7M	Hold	60,633	–	–	0.01%	223
2018 Q4	$1.16M	Sell	60,633 -487	-0.8%	-$11.3K	0.01%	244
2018 Q3	$1.83M	Hold	61,120	–	–	0.01%	238
2018 Q2	$2.24M	Buy	61,120 +10,737	+21%	+$349K	0.01%	216
2018 Q1	$1.66M	Hold	50,383	–	–	0.01%	238
2017 Q4	$1.38M	Hold	50,383	–	–	0.01%	283
2017 Q3	$1.87M	Hold	50,383	–	–	0.01%	247
2017 Q2	$1.92M	Buy	+50,383	New	+$2.24M	0.01%	238

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

TIAA FSB's MDCO Position: Q1 2020 in Review

TIAA FSB sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 60,633 shares — an estimated $5.15M sold.

TIAA FSB first reported a position in MDCO in Q2 2017 and held it in 11 quarters. The position peaked at $5.15M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

TIAA FSB reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
TIAA FSB sold 60,633 Medicines Co shares in Q1 2020, an estimated $5.15M.
TIAA FSB first reported a position in Medicines Co in Q2 2017 and held it in 11 quarters.
TIAA FSB's Medicines Co position peaked at $5.15M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on TIAA FSB's 13F filing for Q1 2020, filed 21 Apr 2020.